“For a patient considering carotid treatment, the most important thing is a second opinion,” says Dr. Hopkins. “When the risk of a procedure is stroke, you want to be sure to choose a well-trained, experienced physician—no matter his or her specialty.”
CREST investigators point out that the rate of stroke and death was the lowest ever reported in a large stroke prevention trial, and while CEA has a proven record and long-term durability, both CAS and CEA are safe and useful tools in the right setting for stroke prevention, especially as advances in technology and patient selection continue to improve each procedure. CAS may be particularly useful for younger patients and for those patients who require a less invasive, less expensive treatment option.
“The CREST trial was a large, complex undertaking that will provide the medical community with important information on the comparative effectiveness of these two procedures. NINDS is committed to long-term follow up of this group of patients, which will help us learn even more about how best to prevent stroke,” said Story Landis, Ph.D., NINDS director.
Partial funding for the study was supplied by Abbott, of Abbott Park, Ill., the maker of the stents.
University at Buffalo Neurosurgery, Inc. (UBNS) is an academic neurosurgical group and leading regional referral center for cerebrovascular disorders run by a distinguished team of neurosurgical specialists and subspecialists committed to superior patient care, resident education, and translational research. UBNS diagnoses and treats a wide range of neurological conditions, inclu
Copyright©2010 Vocus, Inc.
All rights reserved